| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Options Exercise | $0 | +2.77K | +5.88% | $0.00 | 49.8K | Dec 20, 2021 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Options Exercise | $0 | +630 | +1.26% | $0.00 | 50.4K | Dec 20, 2021 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Options Exercise | $0 | +1.45K | +2.87% | $0.00 | 51.9K | Dec 20, 2021 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Tax liability | -$177K | -570 | -1.1% | $311.08 | 51.3K | Dec 20, 2021 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Tax liability | -$77.1K | -248 | -0.48% | $311.08 | 51.1K | Dec 20, 2021 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Tax liability | -$338K | -1.09K | -2.13% | $311.08 | 50K | Dec 20, 2021 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$26.2K | -85 | -0.17% | $308.28 | 49.9K | Dec 21, 2021 | Direct | F1 |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$63.3K | -204 | -0.41% | $310.07 | 49.7K | Dec 21, 2021 | Direct | F2 |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$111K | -356 | -0.72% | $312.67 | 49.3K | Dec 21, 2021 | Direct | F3 |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$73.1K | -233 | -0.47% | $313.61 | 49.1K | Dec 21, 2021 | Direct | F4 |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$58.7K | -190 | -0.39% | $308.81 | 48.9K | Dec 21, 2021 | Direct | F5 |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$112K | -360 | -0.74% | $310.08 | 48.6K | Dec 21, 2021 | Direct | F6 |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$231K | -740 | -1.52% | $312.78 | 47.8K | Dec 21, 2021 | Direct | F7 |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$121K | -386 | -0.81% | $313.48 | 47.4K | Dec 21, 2021 | Direct | F8 |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$314 | -1 | 0% | $314.12 | 47.4K | Dec 21, 2021 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$11.1K | -36 | -0.08% | $308.28 | 47.4K | Dec 21, 2021 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$26.4K | -85 | -0.18% | $310.07 | 47.3K | Dec 21, 2021 | Direct | F9 |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$15.9K | -51 | -0.11% | $312.06 | 47.3K | Dec 21, 2021 | Direct | F10 |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$50.1K | -160 | -0.34% | $313.03 | 47.1K | Dec 21, 2021 | Direct | F11 |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$15.7K | -50 | -0.11% | $313.80 | 47K | Dec 21, 2021 | Direct | F12 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LII | Non-qualified Stock Appreciation Right | Options Exercise | $0 | -8.92K | -100% | $0.00* | 0 | Dec 20, 2021 | Common Stock, Par Value $0.01 Per Share | 8.92K | $214.63 | Direct | F13, F14 |
| transaction | LII | Non-qualified Stock Appreciation Right | Options Exercise | $0 | -5.93K | -33.33% | $0.00 | 11.9K | Dec 20, 2021 | Common Stock, Par Value $0.01 Per Share | 5.93K | $278.00 | Direct | F13, F15 |
| transaction | LII | Non-qualified Stock Appreciation Right | Options Exercise | $0 | -8.35K | -50% | $0.00 | 8.35K | Dec 20, 2021 | Common Stock, Par Value $0.01 Per Share | 8.35K | $257.08 | Direct | F13, F16 |
| Id | Content |
|---|---|
| F1 | These sales (collectively) were effected pursuant to a Rule 10b5-1 trading plan. |
| F2 | Reflects a weighted average sale price of $310.074 at prices ranging from $309.70 to $310.37 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F3 | Reflects a weighted average sale price of $312.665 at prices ranging from $312.09 to $313.03 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F4 | Reflects a weighted average sale price of $313.612 at prices ranging from $313.17 to $314.12 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F5 | Reflects a weighted average sale price of $308.809 at prices ranging from $308.48 to $309.18 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F6 | Reflects a weighted average sale price of $310.075 at prices ranging from $309.70 to $310.37 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F7 | Reflects a weighted average sale price of $312.782 at prices ranging from $312.09 to $313.05 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F8 | Reflects a weighted average sale price of $313.483 at prices ranging from $313.09 to $313.92 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F9 | Reflects a weighted average sale price of $310.071 at prices ranging from $309.70 to $310.37 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F10 | Reflects a weighted average sale price of $312.064 at prices ranging from $311.48 to $312.47 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F11 | Reflects a weighted average sale price of $313.034 at prices ranging from $312.67 to $313.43 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F12 | Reflects a weighted average sale price of $313.803 at pricing ranging from $313.70 to $314.12 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F13 | This exercise was affected pursuant to a Rule 10b5-1 trading plan. |
| F14 | One third of the Stock Appreciation Rights became exercisable on 12/7/2019 and each year thereafter. The entire grant became fully exercisable on 12/7/2021. |
| F15 | One third of the Stock Appreciation Rights became exercisable on 12/11/2021 and each year thereafter. The entire grant will become fully exercisable on 12/11/2023. |
| F16 | One third of the Stock Appreciation Rights became exercisable on 12/13/2020 and each year thereafter. The entire grant will become fully exercisable on 12/13/2022. |